Fresenius Medical Care AG &Co KG (NYSE: FMS) stock closed at $20.76 on 3/5/24 after a major increase of 11.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 284% of normal. The stock has risen 5.4% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, FMS is expected to continue to be an important Value Builder.
Fresenius Medical Care AG &Co KG has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Fresenius Medical Care AG &Co KG has a very high Appreciation Score of 92 but a poor Power Rating of 18, leading to the Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment